Growth factor treatment for spinal cord injury
Part of Brain & nervous system, Injuries & trauma clinical trials.
This trial tests whether your own growth factors, applied to the spinal cord injury site, can help improve recovery. It may be an option if your injury is from trauma and you have some remaining function.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 60 years old and a Chinese citizen.
- Your spinal cord injury was caused by physical trauma, not by disease.
- You have partial loss of function (grade C or D on the ASIA scale), meaning some movement or feeling below the injury is preserved.
- Your injury can be recent or older (acute, subacute, or chronic).
- You can have MRI and nerve tests, which means no metal implants that are not safe for MRI (like certain clips, stents, or stimulators).
- You have no other serious medical conditions (like blood disorders, autoimmune diseases, or infections) and are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new cell therapy called CE-1 for people with spinal cord injuries caused by trauma. The treatment is given as an injection into the fluid around the spinal cord, to see if it helps improve neurological function.
This study tests whether combining electrical stimulation of the spinal cord with personalized physical therapy can improve leg and foot function after a spinal cord injury. If it works, it might help you move better and do more daily activities.
This study tests a combination of two experimental treatments for people with chronic spinal cord injury: an injection of stem cells around the spinal cord, and a non-invasive therapy that uses a mild electrical current on the skin to help the spinal cord work better. The goal is to see if this approach is safe and helps with recovery of movement and function.
This trial tests a new gene therapy called STUP-001 that aims to repair spinal cord damage directly. It is for people who have had a traumatic spinal cord injury with complete or near-complete paralysis (AIS-A or B) for at least 6 months.
This study tests an experimental treatment using special cells (called motor neuron cells) that are injected into the spinal fluid to see if they can help improve recovery after a recent spinal cord injury. It's for people who had a spinal cord injury 2 weeks to 2 months ago and have some loss of function.
This phase 1 trial tests a new treatment made from stem cells (XS228) for people who had a spinal cord injury 14 to 60 days ago. Doctors want to see if it's safe and if it might help with recovery.
Hear when a new Spinal Cord Injury trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.